<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03486262</url>
  </required_header>
  <id_info>
    <org_study_id>NI16034</org_study_id>
    <nct_id>NCT03486262</nct_id>
  </id_info>
  <brief_title>Lung Cancer and Idiopathic Pulmonary Fibrosis : Pathological and Molecular Characterization</brief_title>
  <acronym>K-FPI</acronym>
  <official_title>Lung Cancer and Idiopathic Pulmonary Fibrosis : Pathological and Molecular Characterization</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Retrospective inclusion of lung cancers developed in a context of idiopathic pulmonary
      fibrosis, diagnosed and / or treated in participating centers. The cases are recovered
      retrospectively from the records of the pulmonology and pathology departments of our various
      partners.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Primary objective:

      Characterize altered molecular pathways in lung cancer in patients with IPF versus lung
      cancer in non-IPF patients.

      Secondary objectives:

      Identify specific therapeutic targets Describe a cohort of lung cancers on IPF (clinical /
      radiological and pathological data) To study the relationship between neoplastic /
      preneoplastic lesions and pulmonary parenchyma reshaped by fibrosis.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">February 1, 2018</start_date>
  <completion_date type="Anticipated">February 2020</completion_date>
  <primary_completion_date type="Anticipated">February 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Molecular profile of IPF-associated lung carcinomas</measure>
    <time_frame>1 month / 8 samples</time_frame>
    <description>Next generation sequencing of carcinomas with Ion S5 XL sequencer and Oncomine™ Comprehensive Panel</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pathological characterization of lung carcinomas</measure>
    <time_frame>1 month / 8 samples</time_frame>
    <description>Histological classification of carcinomas and immunohistochemistry with lineage markers</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Lung Cancer and Idiopathic Pulmonary Fibrosis</condition>
  <arm_group>
    <arm_group_label>Lung carcinoma on IPF</arm_group_label>
    <description>Lung carcinoma on IPF</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Formalin fixed paraffin embedded lung samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Retrospective inclusion of lung cancers developed in a context of idiopathic pulmonary
        fibrosis, diagnosed and / or treated in participating centers. The cases are recovered
        retrospectively from the records of the pulmonology and pathology departments of our
        various partners.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Lung carcinoma

          -  Idiopathic pulmonary fibrosis

        Exclusion Criteria:

        - No tumor sample available
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Auréie CAZES, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hopital BICHAT-CLAUDE BERNARD</name>
      <address>
        <city>Paris</city>
        <zip>75018</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 27, 2018</study_first_submitted>
  <study_first_submitted_qc>March 27, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 3, 2018</study_first_posted>
  <last_update_submitted>March 27, 2018</last_update_submitted>
  <last_update_submitted_qc>March 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 3, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Lung cancer; Idiopathic pulmonary fibrosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Pulmonary Fibrosis</mesh_term>
    <mesh_term>Idiopathic Pulmonary Fibrosis</mesh_term>
    <mesh_term>Idiopathic Interstitial Pneumonias</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

